Menu Back to Event-Details

New Collaboration Models with Regulators and Patients

Track:
How Can Better Outcomes Be Enabled by Big Data?

Day & Time:
April 18, 2:00PM - 3:15PM (Central Europe Standard Time)

Session Number:
S0402

Level:
Intermediate

Type:
Session

Title:
New Collaboration Models with Regulators and Patients

Chair(s):
Brian Mayhew, MA, MBA
Executive Director, Regulatory Policy
Novartis Pharmaceuticals Corporation, United States

Description:
This session will explore how the utilisation of advances in technology (such as big data, wearables, cloud computing) will open new opportunities & challenges for collaboration between companies with regulators, payers and patients: Is the present interaction model appropriate; should authorities be involved earlier in data collection & analysis, and how will this change patient engagement?

Presentation(s) & Speaker(s):
Impact of Digital Technology on Drug Development
Bhadri Srinivasan
Head Global Development Operations
Novartis, Switzerland

Regulator Perspective on the Use of New Technology for Evidence Generation on Regulatory Decision Making
Alison Cave, PhD
Principal Scientific Administrator
European Medicines Agency (EMA), United Kingdom

Patient Perspective
Trishna Bharadia
Ambassador
MS Society UK, United Kingdom